On April 5, 2019 NexImmune, an emerging leader in the field of antigen-directed immunotherapy, reported that Scott Carmer, Neximmune’s Chief Executive Officer, will be participating and presenting a corporate update at the following conferences (Press release, NexImmune, APR 5, 2019, View Source [SID1234554954]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Immuno-Oncology Cell Therapy Summit
Friday, April 5th, 3:05PM ET
Boston, MA

Solebury Trout Private Company Showcase
Thursday, April 18th, 10:50AM ET
Boston, MA

On April 5, 2019 ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, reported that Olav Hellebø, the Company’s Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 9, 2019 at 3:30 p.m. BST at the Grosvenor House in London (Press release, ReNeuron, APR 5, 2019, View Source [SID1234535032]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live and archived webcast of the H.C. Wainwright presentation will be available on the Webcasts & Presentations page of the company’s website at www.reneuron.com.

On April 5, 2019 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, reported that John P. Butler, President and Chief Executive Officer, will present at the 18th Annual Needham Healthcare Conference on Tuesday, April 9, 2019 at 11:20 a.m. Eastern Time in New York (Press release, Akebia, APR 5, 2019, View Source [SID1234535029]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the company’s website at www.akebia.com. To access, please log onto the Akebia website at least 15 minutes prior to the webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Akebia’s website following the conference.

On April 5, 2019 Exelixis, Inc. (NASDAQ: EXEL) reported that Christopher J. Senner, the company’s Executive Vice President and Chief Financial Officer, and Andrew R. Peters, the company’s Vice President, Strategy, will provide an overview of the company at the 18th Annual Needham Healthcare Conference taking place on Wednesday, April 10, 2019 in New York, NY (Press release, Exelixis, APR 5, 2019, View Source;p=irol-newsArticle&ID=2393699 [SID1234535028]). The Exelixis presentation is scheduled that day for 4:10 PM EDT / 1:10 PM PDT.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the webcast link, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for 14 days.

On April 5, 2019 TG Therapeutics, Inc. (NASDAQ: TGTX), reported that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 18th Annual Needham Healthcare Conference, being held at the Westin Grand Central Hotel in New York, NY (Press release, TG Therapeutics, APR 5, 2019, View Source [SID1234535026]). The presentation is scheduled to take place on Tuesday, April 9, 2019 at 4:50PM ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at View Source